Melissa G Lechner

15PUBLICATIONS

89CO-AUTHORS

AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursToxicology (incl. clinical toxicology)Neurology and neuromuscular diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jun 11, 2026

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1.

|Jun 23, 2025

Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer.

Alexis LeVee, Esther Peluso, Melissa G Lechner

|Feb 18, 2025

Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant.

Allison T Yip, Teresa H Kim, Esther M Peluso

|Jan 07, 2025

UTX Coordinates TCF1 and STAT3 to Control Progenitor CD8+ T cell Fate in Autoimmune Diabetes.

Ho-Chung Chen, Hsing Hui Wang, Karl B Shpargel

|Dec 16, 2024

Polyfunctional IL-21+ IFNG+ T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy.

Nicole Huang, Jessica Ortega, Kyleigh Kimbrell

|Jun 10, 2024

The Effect of Apalutamide on Thyroid Function in Prostate Cancer Patients.

Clare Moffatt, Melissa G Lechner, Trevor E Angell

Pageof 3

Frequent Collaborators

Maureen A Su

Trevor E Angell

Karen Tsai

Antoni Ribas

Ho-Chung Chen

Alexandra Drakaki

Ethan C McCarthy

Mandy I Cheng

Willy Hugo

Aline T Hoang

Frequent Collaborators

Maureen A Su

Trevor E Angell

Karen Tsai

Antoni Ribas